| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 991 | 2017 |
| Safety and efficacy of pembrolizumab in advanced, programmed death ligand 1–positive cervical cancer: results from the phase Ib KEYNOTE-028 trial JS Frenel, C Le Tourneau, B O’Neil, PA Ott, SA Piha-Paul, C Gomez-Roca, ... Journal of Clinical Oncology 35 (36), 4035-4041, 2017 | 466 | 2017 |
| Tumor clone dynamics in lethal prostate cancer S Carreira, A Romanel, J Goodall, E Grist, R Ferraldeschi, S Miranda, ... Science translational medicine 6 (254), 254ra125-254ra125, 2014 | 393 | 2014 |
| bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses P Jézéquel, JS Frénel, L Campion, C Guérin-Charbonnel, W Gouraud, ... Database 2013, 2013 | 256 | 2013 |
| Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration JS Frenel, S Carreira, J Goodall, D Roda, R Perez-Lopez, N Tunariu, ... Clinical Cancer Research 21 (20), 4586-4596, 2015 | 206 | 2015 |
| Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer P Cottu, V D'hondt, S Dureau, F Lerebours, I Desmoulins, PE Heudel, ... Annals of Oncology 29 (12), 2334-2340, 2018 | 147 | 2018 |
| Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation … W Wick, T Gorlia, P Bady, M Platten, MJ Van Den Bent, MJB Taphoorn, ... Clinical cancer research 22 (19), 4797-4806, 2016 | 147 | 2016 |
| Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases W Jacot, E Pons, JS Frenel, S Guiu, C Levy, PE Heudel, T Bachelot, ... Breast cancer research and treatment 157 (2), 307-318, 2016 | 120 | 2016 |
| Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas D Loussouarn, L Campion, C Sagan, JS Frenel, F Dravet, JM Classe, ... British journal of cancer 98 (12), 1993, 2008 | 97 | 2008 |
| Pembrolizumab in patients with advanced cervical squamous cell cancer: Preliminary results from the phase Ib KEYNOTE-028 study. JS Frenel, C Le Tourneau, BH O'Neil, PA Ott, SA Piha-Paul, ... Journal of Clinical Oncology 34 (15_suppl), 5515-5515, 2016 | 64 | 2016 |
| Oxaliplatin‐based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients JS Frenel, C Leux, L Pouplin, G Ferron, D Berton‐Rigaud, E Bourbouloux, ... Journal of surgical oncology 103 (1), 10-16, 2011 | 63 | 2011 |
| Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations D Figarella-Branger, POLA Network, K Mokhtari, POLA Network, ... Neuro-oncology 16 (9), 1244-1254, 2014 | 61 | 2014 |
| Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series MJ Rodrigues, J Peron, JS Frénel, YA Vano, J Wassermann, M Debled, ... Annals of oncology 24 (4), 916-924, 2012 | 58 | 2012 |
| Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas D Loussouarn, AG Le Loupp, JS Frenel, F Leclair, A Von Deimling, ... International journal of oncology 40 (6), 2058-2062, 2012 | 58 | 2012 |
| Results of the phase Ib Keynote-028 multi-cohort trial of pembrolizumab monotherapy in patients with recurrent PD-L1-positive glioblastoma multiforme (GBM) DA Reardon, TM Kim, JS Frenel, A Santoro, J Lopez, DS Subramaniam, ... Neuro-Oncology 18, 25-26, 2016 | 50 | 2016 |
| ATIM-35. Results of the phase IB KEYNOTE-028 multi-cohort trial of pembrolizumab monotherapy in patients with recurrent PD-L1-positive glioblastoma multiforme (GBM) DA Reardon, TM Kim, JS Frenel, A Santoro, J Lopez, DS Subramaniam, ... Neuro-Oncology 18 (suppl_6), vi25-vi26, 2016 | 50 | 2016 |
| Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy P Augereau, A Patsouris, E Bourbouloux, C Gourmelon, ... Therapeutic advances in medical oncology 9 (5), 335-346, 2017 | 49 | 2017 |
| Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003 AM Fontenoy, C Leux, S Delacour-Billon, C Allioux, JS Frenel, ... Cancer Epidemiology 34 (3), 238-243, 2010 | 43 | 2010 |
| 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study A Ploquin, B Pistilli, E Tresch, JS Frenel, F Lerebours, A Lesur, ... European Journal of Cancer 95, 30-37, 2018 | 38 | 2018 |
| Allelic loss of 9p21. 3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas A Alentorn, C Dehais, F Ducray, C Carpentier, K Mokhtari, ... Neurology 85 (15), 1325-1331, 2015 | 38 | 2015 |
